Adult Stem Cells Market
Adult Stem Cells Market Global Industry Assessment & Forecast
#
Pages:
169
2021
Nov - 2021
VMR-2021-0190
Segments Covered
By
Type Epithelial Stem Cells, Hematopoietic Stem Cells
-
By
Application Neurodegenerative Diseases, Heart Diseases, Bone Diseases, Others
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
6.94 Billion |
 Revenue 2028:
|
9.45 Billion |
 Revenue CAGR
(2021 - 2028): |
7.5 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
The report delivers an acute breakdown of the market based on various segments such as Type, Application and region. This study comprises the market size in terms of revenue for each segment at the global/regional/country level along with a detailed analysis of growth prospects, challenges, and opportunities.
On the basis of Type, the market is divided into Epithelial Stem Cells, Hematopoietic Stem Cells. Epithelial Stem Cells is expected to dominate the market and is projected to grow at a noteworthy CAGR within the forecast period.
Based on Application, the market is divided into Neurodegenerative Diseases, Heart Diseases, Bone Diseases, Others. Neurodegenerative Diseases attributed to the highest market share and is expected to grow at a significant CAGR from 2021 to 2028.
Global Adult Stem Cells Market: Type Segment Analysis
-
- Epithelial Stem Cells
- Hematopoietic Stem Cells
Global Adult Stem Cells Market: Application Segment Analysis
-
- Neurodegenerative Diseases
- Heart Diseases
- Bone Diseases
- Others
FAQ
Frequently Asked Question
What is the global demand for Adult Stem Cells in terms of revenue?
-
The global Adult Stem Cells valued at 6.94 Billion in 2020 and is expected to reach 9.45 Billion in 2028 growing at a CAGR of 7.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Intellicell Biosciences Inc., Globalstem, Neurogeneration, Capricor Inc., Caladrius Biosciences Inc., Mesoblast Ltd., Celyad, Juventas Therapeutics Inc., Cytori Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Brainstorm Cell Therapeutics Inc., Cellerant Therapeutics Inc., Hybrid Organ Gmbh, Cellerix Sa..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.5% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Adult Stem Cells include
- The determinants driving to the growth are rising demand for biologics, advancement in technology in stem cell therapeutics, and rising focus on the advancement of personalized medicines.
- The rising focus on the medical care of neurological disorders is also fueling to the market expansion.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Adult Stem Cells in 2020.
